SINGH SHAWN (CHIEF EXECUTIVE OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/2/2024ACC: 0001415889-24-019020
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Aug 2018
+4.85K
Net shares
Net buyer
$14.4K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4.85K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.85K
Price / share
$2.96
Trade value
$14.36K
% of position
86.2%
6/28/2024
5.63K→10.49K
Total
Net shares
+4.85K
Net value
$14.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/28/2024 | A · Award | +4.85K | $2.96 | $14.36K | 86.2% | 5.63K | 10.49K |
| Total | +4.85K | $14.36K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20.88K
Total
20.88K indirect20.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.88K | Indirect |
| Total | 20.88K | 20.88K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported